Cluster Headache Treatment
Acute Treatment
For acute cluster headache attacks, use subcutaneous sumatriptan 6 mg or high-flow oxygen (100% at ≥12 L/min for 15 minutes) as first-line therapy. 1
Primary Acute Options:
- Subcutaneous sumatriptan 6 mg is the most effective acute treatment, with rapid onset matching the quick escalation of cluster headache pain 1, 2
- 100% oxygen at ≥12 L/min for 15 minutes via non-rebreather mask is equally effective and has no contraindications 1, 2
- Intranasal zolmitriptan 10 mg serves as an alternative when subcutaneous administration is not feasible 1
Key Considerations for Acute Treatment:
The 2024 VA/DoD guidelines provide only weak recommendations for these treatments 1, but the 2023 European Academy of Neurology guidelines give strong recommendations for both oxygen and subcutaneous sumatriptan 2. The rapid onset of cluster attacks (often reaching peak intensity within minutes) necessitates fast-acting delivery routes—oral medications are generally inadequate 3, 4.
Common pitfall: Triptans have cardiovascular contraindications and maximum daily use limits (typically 2 doses per 24 hours), which can be problematic given that cluster patients may experience multiple attacks daily 5. Oxygen therapy avoids these limitations entirely 2.
Short-Term Preventive (Bridge/Transitional) Treatment
Use oral corticosteroids (prednisone ≥100 mg daily or equivalent) or greater occipital nerve blocks as bridge therapy while initiating long-term preventive treatment. 2, 3
Bridge Therapy Options:
- Prednisone 100 mg orally daily (or up to 500 mg IV over 5 days) provides rapid suppression of attacks while waiting for maintenance preventives to take effect 2
- Greater occipital nerve block with local anesthetic and corticosteroid is recommended as an alternative bridge option 2, 4
Rationale for Bridge Therapy:
Bridge therapy is essential for patients experiencing ≥2 attacks daily, as maintenance preventives like verapamil require weeks to reach therapeutic effect 4. Corticosteroids cannot be used long-term due to side effects, making them ideal for 1-2 week transitional periods 3, 6.
Long-Term Preventive Treatment
Verapamil at ≥240 mg daily (titrated based on efficacy and tolerability) is the first-line preventive treatment for both episodic and chronic cluster headache. 2, 3
Primary Preventive Options:
First-Line:
- Verapamil starting at 240 mg daily, titrated upward (often to 480-960 mg daily in divided doses) until attacks are controlled 2, 6
- Critical safety requirement: Obtain baseline ECG and repeat ECGs with each dose increase to monitor for cardiac conduction abnormalities (PR interval prolongation, heart block) 4, 5
- The 2024 VA/DoD guidelines state insufficient evidence for verapamil 1, but this contradicts the 2023 European Academy of Neurology strong recommendation and decades of clinical experience 2
Alternative Preventives:
- Galcanezumab (CGRP monoclonal antibody) is recommended specifically for episodic cluster headache only—it is NOT effective for chronic cluster headache 1, 2
- Lithium (600-900 mg daily with therapeutic monitoring) is an alternative, particularly for chronic cluster headache, but requires regular blood level monitoring and has significant drug interactions 2, 6
- Topiramate (up to 200 mg daily) has some evidence as a second-line option 2, 6
Treatment Algorithm:
- Start verapamil with ECG monitoring while simultaneously using bridge therapy (corticosteroids or nerve block) 2, 3
- If verapamil is contraindicated (cardiac conduction disease) or ineffective at maximum tolerated dose, consider lithium or topiramate 6, 4
- For episodic cluster headache specifically, galcanezumab is an evidence-based alternative 1, 2
- For treatment-refractory chronic cluster headache, consider neuromodulation (occipital nerve stimulation) 3, 7
Critical pitfall: The distinction between episodic and chronic cluster headache matters for galcanezumab—do not use it for chronic cluster headache as evidence shows it is ineffective in this population 1.